Skip to content
Menu

Cardinal Health, Inc. CAH

Full chart Compare
Set alert

Price alert · CAH

All alert types
281.10 USD +2.96 (+1.06%)

Regular-session close

284.68 +3.58 +1.27%

Pre-market · Nov 16, 6:17 AM ET

276.75 Day range 281.86
180.45 52-week range 286.29
YTD
+36.79%
1 year
+36.42%
Market cap
64.97B
Revenue (ttm)
257.75B
Profit margin
0.70%
EPS (ttm)
7.73
Shares out
231.14M
P/E ratio
36.36
Forward P/E
19.55
Dividend
2.06 (0.74%)
Ex-dividend date
Oct 1, 2026
YTD return
+36.79%
1-year return
+36.42%
Volume
1.25M
Avg volume
1.71M
Open
280.09
Previous close
278.14
Day's range
276.75 – 281.86
52-week range
180.45 – 286.29
Beta
0.52
Analysts
Buy
Price target
294.87 (+4.9%)
Earnings date
Feb 4, 2027

5D +6.02 (+2.19%)

275280MonTueWedThuFri281.10

Key statistics

Enterprise value
68.00B
PEG ratio
1.32
Price / sales
0.25
Price / book
0.00
Dividend yield
0.74%
Payout ratio
26.56%
Revenue growth
5.50%
Free cash flow
5.02B
Total cash
5.26B
Total debt
8.81B
Return on equity
0.00%
Short % of float
3.27%
50-day average
243.54
200-day average
224.75

Fundamental scorecard

16 of 25 checks passed on CAH’s reported financials

Value: 1/5ValueGrowth: 5/5GrowthProfitability: 3/5ProfitabilityFinancial health: 3/5HealthDividend: 4/5Dividend

16of 25 checks passed

  • Value 1 of 5
  • Growth 5 of 5
  • Profitability 3 of 5
  • Financial health 3 of 5
  • Dividend 4 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
CAH Revenue — quarterly 67.51B
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
CAH Net income — quarterly 554.00M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
CAH EPS — quarterly 2.39
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026

Earnings

CAH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 4, 2027Dec 30, 20263.15———
Nov 5, 2026Sep 30, 20262.943.26+0.32+10.88%
Aug 11, 2026Jun 30, 20262.422.91+0.49+20.25%
Apr 30, 2026Mar 31, 20262.793.17+0.38+13.62%
Feb 5, 2026Dec 31, 20252.342.63+0.29+12.39%
Oct 30, 2025Sep 30, 20252.182.55+0.37+16.97%

Upgrades / downgrades

CAH analyst upgrades and downgrades
DateFirmActionFromTo
Nov 12, 2026Argus ResearchmainBuyBuy
Nov 10, 2026JP MorganmainNeutralNeutral
Nov 9, 2026TD CowenmainBuyBuy
Nov 6, 2026RBC CapitalmainOutperformOutperform
Nov 6, 2026Evercore ISI GroupmainOutperformOutperform
Oct 30, 2026Morgan StanleymainOverweightOverweight

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Sector
Healthcare
Industry
Medical Distribution
Country
United States

News

Your note

Sign in to keep a note on CAH — it syncs with the Stock Master app.

Insider holders

CAH insider holders
InsiderRelationLatest transactionDateShares held
ALT AARON E.Chief Financial OfficerSaleAug 17, 202620,495
HALL PATRICIA HEMINGWAYDirectorStock Award(Grant)Apr 14, 202628,645
HOLLAR JASON MChief Executive OfficerSaleAug 18, 2026190,603
JOHRI AKHILDirectorStock Award(Grant)Nov 4, 202522,868
KENNY GREGORY BDirectorStock Award(Grant)Nov 4, 202564,194
KILLEFER NANCYDirectorStock Award(Grant)Nov 4, 202527,624

Institution ownership

CAH institution ownership
Holder% heldSharesValueReported
Blackrock Inc.11.46%26,490,6337.45BJun 29, 2026
Vanguard Capital Management LLC6.62%15,292,1864.30BJun 29, 2026
Wellington Management Group, LLP6.43%14,860,2714.18BJun 29, 2026
Vanguard Portfolio Management LLC5.93%13,717,8943.86BJun 29, 2026
State Street Corporation5.21%12,049,6743.39BSep 29, 2026
Geode Capital Management, LLC2.79%6,454,5111.81BSep 29, 2026

Fund ownership

CAH fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.22%7,434,9022.09BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.63%6,067,5181.71BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.20%5,074,7081.43BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.34%3,099,179871.12MSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.31%3,022,553849.58MSep 29, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.24%2,870,270806.78MSep 29, 2026